论文部分内容阅读
抗肿瘤坏死因子（TNF）-α单克隆抗体（单抗）可用于儿童克罗恩病的诱导和维持缓解治疗，但目前国内尚缺乏抗TNF-α单抗治疗儿童克罗恩病的共识或指南，国内炎症性肠病领域的儿科专家借鉴国外最新指南以及国内抗TNF-α单抗治疗儿童克罗恩病的临床研究，特制定本共识，以进一步规范抗TNF-α单抗在儿童克罗恩病的治疗，为儿童克罗恩病的临床管理提供指导性意见。“,”Anti-tumor necrosis factor (TNF) -α monoclonal has been used to induce and maintain remission in pediatric Crohn′s disease. However, there is no consensus or guidelines on the management of pediatric Crohn′s disease with anti-TNF-α therapy in China. Chinese pediatric inflammatory bowel disease experts combined the latest foreign guidelines and Chinese clinical research on anti-TNF-α in children to formulate this consensus in order to further standardize the management of pediatric Crohn′s disease with anti-TNF-α therapy and guide for the clinical management of pediatric Crohn′s disease.